Laura is President and Founder of Endeavor Pharma Solutions, a specialized pharmaceutical market access consulting firm. A Harvard MBA and recipient of the 2023 Baldrige Foundation Award for Leadership Excellence, Laura brings over 20 years of pharmaceutical industry experience to her role as a strategic advisor, including a decade in senior leadership positions at Lilly. Her expertise spans pricing optimization, payer engagement, and patient support program design. Throughout her career, Laura has architected sophisticated market access strategies that helped breakthrough therapies reach their full commercial potential. She is recognized for her ability to transform complex market challenges into actionable solutions that drive measurable business results.